Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang Xinma Pharmaceutical is a comprehensive pharmaceutical enterprise based in Shenyang, China, and operates as a key subsidiary of Liaoning Cheng Da. The company is primarily engaged in the research, development, and manufacturing of chemical pharmaceuticals, with a product portfolio spanning anti-infectives, cardiovascular agents, and gastrointestinal drugs. Its manufacturing facilities are equipped with advanced production lines for sterile powder injections, small-volume injections, and solid oral dosage forms, all adhering to national GMP standards. Xinma Pharmaceutical focuses on providing high-quality generic medications and has established a significant presence in the Chinese domestic healthcare market. The company leverages its parent organization's resources to enhance its distribution network and R&D capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang Xinma Pharmaceutical.